Clinical Trial Detail

NCT ID NCT01701037
Title Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Vanderbilt-Ingram Cancer Center
Indications

melanoma

Therapies

Dabrafenib + Trametinib

Dabrafenib

Age Groups: adult

Additional content available in CKB BOOST